Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kymera Therapeutics (KYMR) Interest Coverage Ratio (2019 - 2025)

Historic Interest Coverage Ratio for Kymera Therapeutics (KYMR) over the last 7 years, with Q3 2025 value amounting to 944.09.

  • Kymera Therapeutics' Interest Coverage Ratio rose 2146.09% to 944.09 in Q3 2025 from the same period last year, while for Sep 2025 it was 985.93, marking a year-over-year decrease of 1918.33%. This contributed to the annual value of 1050.74 for FY2024, which is 2441.59% down from last year.
  • Per Kymera Therapeutics' latest filing, its Interest Coverage Ratio stood at 944.09 for Q3 2025, which was up 2146.09% from 782.94 recorded in Q2 2025.
  • Over the past 5 years, Kymera Therapeutics' Interest Coverage Ratio peaked at 371.38 during Q4 2023, and registered a low of 1402.66 during Q3 2023.
  • For the 5-year period, Kymera Therapeutics' Interest Coverage Ratio averaged around 884.82, with its median value being 883.21 (2021).
  • Its Interest Coverage Ratio has fluctuated over the past 5 years, first soared by 4327.8% in 2023, then plummeted by 26854.75% in 2024.
  • Kymera Therapeutics' Interest Coverage Ratio (Quarter) stood at 666.55 in 2021, then rose by 1.77% to 654.75 in 2022, then surged by 43.28% to 371.38 in 2023, then tumbled by 268.55% to 1368.73 in 2024, then skyrocketed by 31.02% to 944.09 in 2025.
  • Its last three reported values are 944.09 in Q3 2025, 782.94 for Q2 2025, and 1033.69 during Q1 2025.